ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 983

Identifying Exposures to Chemicals in Patients with SLE – a Non-Targeted Exposome Approach Reveals Enrichment for Phthalates

Cristina Lanata1, Thomas Lin2, Maria Dall'Era1, Jinoos Yazdany3, Patricia P. Katz1, Laura Trupin3, Charles G. Helmick4, Roy Gerona5 and Lindsey A. Criswell1, 1Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 2Univeristy of California, San Francisco, SAN FRANCISCO, CA, 3Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 4Centers for Disease Control and Prevention, Atlanta, GA, 5Obstetrics and Gynecology, University of California, San Francisco, SAN FRANCISCO, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Lupus and environmental factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Epidemiology and Public Health Poster II: Rheumatic Diseases Other than Rheumatoid Arthritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Environmental exposures may play a substantial role in the pathogenesis of SLE. The goal of this study is to characterize the serum levels of multiple chemicals in a cohort of SLE patients and controls.

Methods:

Patients from the California Lupus Epidemiology Study and healthy controls were studied. Banked serum was analyzed by Liquid Chromatography Quadruple Time-of-Flight Mass Spectrometry (LC-QTOF/MS). The results of the LC-QTOF/MS analysis were matched into a database of 740 potentially detected environmental organic chemicals. Detection frequencies of chemicals were calculated. Univariate and multivariate analyses were performed, adjusting for potential confounders. Association testing between chemical classes, chemicals and specific lupus phenotypes and disease activity was performed.

Results:

58 females with SLE and 78 healthy females were studied. The number of unique chemicals detected was 309, with an average of 60 chemical-hit matches per subject (range 32-150). SLE patients had a higher detection frequency of phthalates whereas healthy controls had a higher detection frequency of pesticides and phenols (table 1). A higher phthalate detection frequency was associated lupus nephritis, but did not correlate with disease activity (SLEDAI score), hypocomplementemia or anti ds-DNA status. In patients with SLE, a per count increase in detection frequency of a phthalate was associated with an OR of 1.4 for history of lupus nephritis, adjusting for age, disease duration, race, education and income (p=0.002, CI[1.1-1.7]). Chemicals detected at a higher frequency in SLE were enriched for specific phthalates such as metabolites of DHEP (table 2). Among SLE patients, 2 specific phthalates, mono2ethyl5oxohexylphthalate (p=0.00002) and mono2ethyl5oxohexylphthalate (p=0.00015) were associated with lupus nephritis.

Conclusion:

LC-QTOF/MS can identify a wider range of potential chemical exposures in SLE, and may aid in prioritizing chemicals for further research and intervention.  We found that patients with SLE had significantly increased exposure to phthalates compared to healthy controls, with further enrichment among patients with lupus nephritis. Exposure to Mono-(2-carboxymethylhexyl) phthalate has been associated with dsDNA production and lupus nephritis in NZB/W F1 mice.

 


Disclosure: C. Lanata, None; T. Lin, None; M. Dall'Era, None; J. Yazdany, None; P. P. Katz, Bristol-Myers Squibb, 2; L. Trupin, None; C. G. Helmick, None; R. Gerona, None; L. A. Criswell, None.

To cite this abstract in AMA style:

Lanata C, Lin T, Dall'Era M, Yazdany J, Katz PP, Trupin L, Helmick CG, Gerona R, Criswell LA. Identifying Exposures to Chemicals in Patients with SLE – a Non-Targeted Exposome Approach Reveals Enrichment for Phthalates [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/identifying-exposures-to-chemicals-in-patients-with-sle-a-non-targeted-exposome-approach-reveals-enrichment-for-phthalates/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-exposures-to-chemicals-in-patients-with-sle-a-non-targeted-exposome-approach-reveals-enrichment-for-phthalates/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology